MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC

Qin Li,1,2,* Qin Xiao,2,3,* Jianwei Li,3,4 Shaofeng Duan,5 He Wang,6 Yajia Gu2,3 1Shanghai Institute of Medical Imaging, Shanghai, China; 2Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; 3Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai, Ch...

Full description

Bibliographic Details
Main Authors: Li Q, Xiao Q, Li J, Duan S, Wang H, Gu Y
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/mri-based-radiomic-signature-as-a-prognostic-biomarker-for-her2-positi-peer-reviewed-article-CMAR